Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias F Kramer

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Vaccines|September 28, 2017
Microcrystalline Tyrosine (MCT<sup>®</sup>): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in MalariaGustavo Cabral-Miranda, Matthew D Heath, Ariane C Gomes, et al.
Allergy|October 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergyPascal S Krenger, Romano Josi, Jan Sobczak, et al.
Toxins|September 26, 2021
Venom Immunotherapy: From Proteins to Product to Patient ProtectionMartin Feindor, Matthew D Heath, Simon J Hewings, et al.
Journal of Clinical Medicine|December 30, 2025
Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. <i>J. Clin. Med.</i> 2025, <i>14</i>, 2609Michael Gerstlauer, Julia Hiller, Jennifer Raab, et al.
Journal of Clinical Medicine|April 26, 2025
TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early ResultsMichael Gerstlauer, Julia Hiller, Jennifer Raab, et al.
Vaccines|May 5, 2017
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivaxGustavo Cabral-Miranda, Matthew D Heath, Mona O Mohsen, et al.
Allergy|July 21, 2021
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergyAlexander Heldner, Francesca Alessandrini, Dennis Russkamp, et al.
Diseases (Basel, Switzerland)|November 25, 2018
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based VaccinesGustavo Cabral-Miranda, Ahmed M Salman, Mona O Mohsen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 13, 2021
Micronutritional supplementation with a holoBLG-based FSMP (food for special medical purposes)-lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effectSheriene Moussa Afify, Andreas Regner, Luis F Pacios, et al.
Toxins|April 21, 2022
Allergen Content of Therapeutic Preparations for Allergen-Specific Immunotherapy of European Paper Wasp Venom AllergyJohannes Grosch, Antoine Lesur, Stéphanie Kler, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Vaccines|September 28, 2017
Microcrystalline Tyrosine (MCT<sup>®</sup>): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in MalariaGustavo Cabral-Miranda, Matthew D Heath, Ariane C Gomes, et al.
Allergy|October 10, 2023
Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergyPascal S Krenger, Romano Josi, Jan Sobczak, et al.
Toxins|September 26, 2021
Venom Immunotherapy: From Proteins to Product to Patient ProtectionMartin Feindor, Matthew D Heath, Simon J Hewings, et al.
Journal of Clinical Medicine|December 30, 2025
Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. <i>J. Clin. Med.</i> 2025, <i>14</i>, 2609Michael Gerstlauer, Julia Hiller, Jennifer Raab, et al.
Journal of Clinical Medicine|April 26, 2025
TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early ResultsMichael Gerstlauer, Julia Hiller, Jennifer Raab, et al.
Vaccines|May 5, 2017
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivaxGustavo Cabral-Miranda, Matthew D Heath, Mona O Mohsen, et al.
Allergy|July 21, 2021
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergyAlexander Heldner, Francesca Alessandrini, Dennis Russkamp, et al.
Diseases (Basel, Switzerland)|November 25, 2018
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based VaccinesGustavo Cabral-Miranda, Ahmed M Salman, Mona O Mohsen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 13, 2021
Micronutritional supplementation with a holoBLG-based FSMP (food for special medical purposes)-lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effectSheriene Moussa Afify, Andreas Regner, Luis F Pacios, et al.
Toxins|April 21, 2022
Allergen Content of Therapeutic Preparations for Allergen-Specific Immunotherapy of European Paper Wasp Venom AllergyJohannes Grosch, Antoine Lesur, Stéphanie Kler, et al.
Pageof 8